Skip to main content
. 2021 Dec 23;8:756237. doi: 10.3389/fmed.2021.756237

Table 2.

Difference in the treatment drugs between the survival and non-survival groups.

Drugs
(n, %)
Survivors
(n = 85)
Non-survivors
(n = 32)
P-value
Voriconazole 70 (82.4) 24 (75.0) 0.278
Amphotericin B 8 (9.4) 3 (9.4) 1.0
Echinocandins 3 (3.5) 3 (9.4) 0.343
Posaconazole 3 (3.5) 1 (3.1) 1.0
Itraconazole 1 (1.1) 1 (3.1) 0.481
Combination therapy 2 (2.4) 0 (0) 0.560